Astellas Enters into Yet Another Agreement
By Business Review Editor
Pharma Deals Review: Vol 2006 Issue 72 (Table of Contents)
Published: 1 Jun-2006
DOI: 10.3833/pdr.v2006.i72.503 ISSN: 1756-7874
Section: Features
Fulltext:
Abstract
The licensing of FibroGen's portfolio of anaemia therapeutics to Astellas Pharma that is reported here gives an insight into both the value and scope of the anaemia market, and the business strategies of the partnering companies...
This page is available to subscribers only.
Not a subscriber? Join here
Already Registered? Please login using the top left purple box.
Copyright: © IQVIA 2018
RSS